"10.1371_journal.pone.0115540","plos one","2015-01-28T00:00:00Z","Katharina Zetterström; Margaretha Voss; Kristina Alexanderson; Torbjörn Ivert; Kenneth Pehrsson; Niklas Hammar; Marjan Vaez","Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Analysis and Forecasts, Swedish Social Insurance Agency, Stockholm, Sweden; Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Stockholm, Sweden; AstraZeneca R&D, Mölndal, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Occupational and Environmental Medicine, Stockholm County Council, Stockholm, Sweden","Conceived and designed the experiments: KZ M. Voss KA TI KP NH M. Vaez. Performed the experiments: KZ M. Voss M. Vaez. Analyzed the data: KZ M. Voss M. Vaez. Contributed reagents/materials/analysis tools: KZ M. Voss KA TI KP NH M. Vaez. Wrote the paper: KZ M. Voss KA TI KP NH M. Vaez. Interpretation of data: KZ M. Voss KA TI KP NH M. Vaez. Revised the manuscript critically for important intellectual content: KZ M. Voss KA TI KP NH M. Vaez.","Professor Niklas Hammar is Regional Manager Epidemiology Europe, Global Epidemiology, for AstraZeneca Research & Development. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. The authors have declared that no competing interests exist.","2015","01","Katharina Zetterström","KZ",7,FALSE,2,2,2,2,TRUE,TRUE,TRUE,4,"3;4;5;6",TRUE
